Zevra Therapeutics (ZVRA) to Join Nasdaq Biotechnology Index (NBI)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/6/2026

1. PTC
2. NVDA
3. PCVX
4. META
5. MSFT
6. SPY
7. GOOGL
8. GMAB
9. USO
10. AMD

Go back to Zevra Therapeutics (ZVRA) to Join Nasdaq Biotechnology Index (NBI)

Zevra Therapeutics to be Added to Nasdaq Biotechnology Index (Nasdaq: NBI) Effective December 23, 2024

December 17, 2024 7:30 AM EST

CELEBRATION, Fla., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on addressing unmet needs for the treatment of rare diseases, today announced its upcoming addition to the Nasdaq Biotechnology Index (Nasdaq: NBI) (NBI) as part of the annual reconstitution of the 2024 Nasdaq indexes. Zevras inclusion in the NBI will be effective after the U.S. market opens on Monday, December 23, 2024.

The past year has been transformational for Zevra as we continue to drive awareness among the investment... More